# Advanced BioNutrition

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/advanced-bionutrition

- Industry: Consumer Products
- Headquarters: Columbia, US
- Website: www.abn-corp.com
- Total disclosed funding: $19M
- Latest round: Series C (May 27, 2011)
- Investors on record: 9

## About

Advanced BioNutrition Corp. focuses on developing innovative stabilization and delivery solutions for bioactives in human health, agriculture, and food safety, addressing essential challenges in product efficacy and sustainability.Advanced BioNutrition Corp. specializes in bioactive stabilization and delivery solutions. The company is headquartered in Columbia, US. It was co-founded by William Kirk, who has a history of founding companies in the biotechnology sector. The most recent funding round occurred on May 27, 2011, when the company raised USD 1.15 mn in a Series C round from investors including BASF, Emerald Technology Ventures, Sherbrooke Capital, and The Sea Change Investment Fund. This funding brought the total amount raised by the company to USD 1.15 mn with a current company valuation of USD 35.068 mn.Advanced BioNutrition Corp. (ABN) specializes in developing environmentally sustainable bioactive stabilization and delivery solutions across various industries, such as human health, agriculture, and food safety. The company holds over 40 patents that support the stabilization and delivery of bioactives, including probiotics, vaccines, and supplements aimed at enhancing human health. In agriculture, ABN offers technologies designed to stabilize and deliver agricultural bioactives, ensuring crop quality and sustainability. Their diverse clientele includes health supplement manufacturers and agricultural entities primarily located in North America, Europe, and select markets in Asia and South America, addressing critical challenges in product efficacy and stability.Advanced BioNutrition Corp. generates revenue through strategic partnerships and direct business engagements, emphasizing B2B transactions with clients in health and agriculture sectors. The company collaborates closely with clients during technology development and transfer, ensuring tailored solutions. Revenue streams include long-term contracts with supplement manufacturers and agricultural businesses, where clients typically purchase technology licenses or enter subscription agreements for ongoing support and product development. ABN's patented technologies enhance product stability and delivery, leading to increased efficiencies and cost savings for their clients, fostering a steady revenue flow through consistent service and product innovation.Advanced BioNutrition Corp. plans to leverage its recent funding of USD 1.15 mn raised in May 2011 to support the development of new products aimed at improving bioactive delivery and stabilization. The company is targeting expansion into additional markets in Europe and Asia by 2025, aiming to broaden its reach in the health and agricultural sectors. Recent funding will be utilized to enhance their R&D capabilities, enabling the introduction of innovative solutions tailored to meet emerging client needs in these regions.

## Funding rounds

- Series C, May 27, 2011, $1.1M — Sherbrooke Capital, Emerald Technology Ventures, BASF, The Sea Change Investment Fund
- Series D, May 26, 2011, $0.9M — Sherbrooke Capital, Third Point, Emerald Technology Ventures, BASF, Arancia International, The Sea Change Investment Fund
- Series C, Jun 25, 2007, $7M — Sherbrooke Capital, Emerald Technology Ventures, BASF, Arancia International, The Sea Change Investment Fund
- Series B, Jan 13, 2005, $7.5M — SAM Private Equity, Sherbrooke Capital, Maryland Department of Business and Economic Development, BASF, Eastbourne Capital Management
- Series A, May 20, 2003, $2.5M — Sherbrooke Capital, Maryland Department of Business and Economic Development, Eastbourne Capital Management

## Investors

- Sherbrooke Capital (https://capitalatlas.ai/funds/sherbrooke-capital) — Series A, Series B, Series C, Series D
- Maryland Department of Business and Economic Development — Series A, Series B
- Eastbourne Capital Management — Series A, Series B
- SAM Private Equity (https://capitalatlas.ai/funds/sam-private-equity) — Series B
- BASF (https://capitalatlas.ai/funds/basf) — Series B, Series C, Series D
- Emerald Technology Ventures (https://capitalatlas.ai/funds/emerald-technology-ventures) — Series C, Series D
- Arancia International — Series C, Series D
- The Sea Change Investment Fund — Series C, Series D
- Third Point (https://capitalatlas.ai/funds/third-point) — Series D